about
Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature.Increased High-Sensitivity Troponin-T Levels Are Associated with Mortality After Ischemic Stroke.Bortezomib ocular toxicities: Outcomes with ketotifenThe Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal CancerEmerging serine-threonine kinase inhibitors for treating ovarian cancerPathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancerHaemodialysis-associated thrombocytopenia: interactions among the immune system, membranes and sterilisation methods
P50
Q38813996-5DE99F6A-3A59-467C-90E2-8FA6397AF4EAQ41679426-8BFB6995-73E2-4973-A745-2B5950B9D896Q60781606-AEEB2C5C-9A92-4DBB-8611-3945D2954112Q90050585-99BE889A-4A17-48DB-B928-4D5C5539589DQ91391757-EB887142-7E38-4DD8-8A12-BE942C87EC3AQ92804641-6C2D6818-C17A-410F-AAF1-F6F74E7E0358Q93130877-3F0E644C-DA6C-4DD4-B4B0-BBD4550EC287
P50
description
researcher ORCID ID = 0000-0002-7502-3923
@en
wetenschapper
@nl
name
Asaf Maoz
@ast
Asaf Maoz
@en
Asaf Maoz
@es
Asaf Maoz
@nl
type
label
Asaf Maoz
@ast
Asaf Maoz
@en
Asaf Maoz
@es
Asaf Maoz
@nl
prefLabel
Asaf Maoz
@ast
Asaf Maoz
@en
Asaf Maoz
@es
Asaf Maoz
@nl
P31
P496
0000-0002-7502-3923